Watch Ticker

MiNK Therapeutics, Inc. Common Stock

Go to MiNK Therapeutics, Inc. Common Stock Website

$14.06

0.84 (6.35%)

Live

Previous Close

$13.22

Day Range

$12.69 - $14.37

Previous Day Range

$13.22 - $15.2101

Market Cap

$58.7 million USD

Day Vol.

65064

Previous Day Vol.

321986

Currency

USD

Primary Exchange

Nasdaq

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The co...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

MiNK Therapeutics, a clinical-stage biopharmaceutical company, announced its upcoming virtual Annual Shareholders Meeting and provided updates on its pipeline, including a NIAID grant for its allogeneic iNKT cell therapy for stem cell transplant patients and positive clinical data in various cancer indications.

Related tickers: INKT.

Read Full Article

N/A - MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting

MiNK Therapeutics, a clinical-stage biopharmaceutical company, announced that it will present interim data from its ongoing Phase 2 study testing AgenT-797 in combination with Agenus' botensilimab and balstilimab in patients with refractory gastric cancer.

Related tickers: INKT, AGEN.

Read Full Article

Trending Tickers

Please sign in to view